Literature DB >> 28550388

Antibodies against linear epitopes on Goodpasture autoantigen in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.

Xiao-Yu Jia1, Jun-Tao Yu1,2,3, Shui-Yi Hu1, Jian-Nan Li1, Miao Wang1, Chen Wang1, Min Chen1, Zhao Cui4, Ming-Hui Zhao1,2,3.   

Abstract

In a substantial number of patients with crescentic glomerulonephritis, both anti-glomerular basement membrane (GBM) antibodies and anti-neutrophil cytoplasmic antibodies (ANCA) are detected simultaneously. ANCA is presumed to be the initial event but the mechanism is unknown. In the present study, we investigated the antibodies against linear epitopes on Goodpasture autoantigen in sera from patients with ANCA-associated vasculitis, aiming to reveal the mechanisms of the coexistence of the two kinds of autoantibodies. Thirty-one patients with ANCA-associated vasculitis were enrolled in this study. Twenty-four overlapping linear peptides were synthesized across the whole sequence of Goodpasture autoantigen. Serum antibodies against linear peptides were detected by ELISA and their associations with clinical features were further analyzed. Twenty-five out of the thirty-one (80.6%) sera from patients with ANCA-associated vasculitis possessed antibodies against linear peptides on Goodpasture autoantigen. These antibodies could be detected in 50% of patients with normal renal function (Scr ≤ 133 μmol/L), 70% of patients with moderate renal dysfunction (133 μmol/L < Scr ≤ 600 μmol/L), and 94% of patients with renal failure (Scr > 600 μmol/L) (P = 0.032). The highest recognition frequencies were found for peptides P4 (51.6%), P14 (54.8%), and P24 (54.8%), which contained the sequences that constitute the conformational epitopes of EA (P4) and EB (P14) recognized by anti-GBM antibodies. The level of anti-P4 antibodies was positively correlated with the percentage of crescents in glomeruli (r = 0.764, P = 0.027). Patients with anti-P24 antibodies had a significantly higher prevalence of renal dysfunction on diagnosis (88.2 vs. 42.9%, P = 0.018). Antibodies against linear epitopes on Goodpasture autoantigen could be detected in sera of patients with ANCA-associated vasculitis, which might mediate the production of antibodies towards the conformational epitopes on Goodpasture autoantigen, namely, the anti-GBM antibodies.

Entities:  

Keywords:  ANCA; Anti-GBM antibodies; Crescentic glomerulonephritis; Linear epitopes; α3(IV)NC1

Mesh:

Substances:

Year:  2017        PMID: 28550388     DOI: 10.1007/s10067-017-3692-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

1.  T-cell epitope of alpha3 chain of type IV collagen induces severe glomerulonephritis.

Authors:  Jean Wu; Jason Borillo; William F Glass; John Hicks; Ching-Nan Ou; Ya-Huan Lou
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

Review 2.  Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.

Authors:  Abraham Rutgers; Marjan Slot; Pieter van Paassen; Peter van Breda Vriesman; Peter Heeringa; Jan Willem Cohen Tervaert
Journal:  Am J Kidney Dis       Date:  2005-08       Impact factor: 8.860

3.  Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.

Authors:  R Kalluri; T M Danoff; H Okada; E G Neilson
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

4.  Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury.

Authors:  Xiao-yu Jia; Zhao Cui; Rui Yang; Shui-yi Hu; Ming-hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-29       Impact factor: 8.237

5.  Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies.

Authors:  Rui Yang; Thomas Hellmark; Juan Zhao; Zhao Cui; Marten Segelmark; Ming-Hui Zhao; Hai-Yan Wang
Journal:  J Am Soc Nephrol       Date:  2007-02-28       Impact factor: 10.121

6.  Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway.

Authors:  Damian N Meli; Stephan Christen; Stephen L Leib
Journal:  J Infect Dis       Date:  2003-04-15       Impact factor: 5.226

7.  Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.

Authors:  Yuki Hamano; Michael Zeisberg; Hikaru Sugimoto; Julie C Lively; Yohei Maeshima; Changqing Yang; Richard O Hynes; Zena Werb; Akulapalli Sudhakar; Raghu Kalluri
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

8.  Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.

Authors:  Rui Yang; Thomas Hellmark; Juan Zhao; Zhao Cui; Marten Segelmark; Ming-Hui Zhao; Hai-Yan Wang
Journal:  Nephrol Dial Transplant       Date:  2009-01-16       Impact factor: 5.992

9.  A self T cell epitope induces autoantibody response: mechanism for production of antibodies to diverse glomerular basement membrane antigens.

Authors:  Jean Wu; Jon Arends; Jason Borillo; Cindy Zhou; Justin Merszei; John McMahon; Ya-Huan Lou
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

10.  Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis.

Authors:  Shen-Ju Gou; Peng-Cheng Xu; Min Chen; Ming-Hui Zhao
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more
  2 in total

1.  Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: "All that glitters is not scleroderma renal crisis".

Authors:  Renaud Felten; Benoît Nespola; Emmanuel Chatelus; Laurent Arnaud; Jacques-Eric Gottenberg; Matthieu Canuet; Eric Prinz; Joëlle Goetz; Jean Sibilia
Journal:  J Scleroderma Relat Disord       Date:  2019-04-02

2.  H1N1 influenza virus epitopes classified by monoclonal antibodies.

Authors:  Chunyan Guo; Haixiang Zhang; Xin Xie; Yang Liu; Lijun Sun; Huijin Li; Pengbo Yu; Hanyu Hu; Jingying Sun; Yuan Li; Qing Feng; Xiangrong Zhao; Daoyan Liang; Zhen Wang; Jun Hu
Journal:  Exp Ther Med       Date:  2018-07-09       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.